melatonin has been researched along with Disbacteriosis in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the present study was to investigate the impact of a short-term feeding with HFD on oxidative status, enteric microbiota, intestinal motility and the effects of antibiotics and/or melatonin treatments on diet-induced hepato-intestinal dysfunction and inflammation." | 7.91 | The effects of antibiotics and melatonin on hepato-intestinal inflammation and gut microbial dysbiosis induced by a short-term high-fat diet consumption in rats. ( Akdeniz, E; Aksu, B; Arabacı Tamer, S; Bagriacik, F; Cayirli, YB; Çetinel, Ş; Cilingir Kaya, ÖT; Kahraman, MM; Onur, ND; Sahin, D; Yeğen, BÇ; Yildirim, A; Yuksel, M, 2019) |
| "Melatonin is an endogenous hormone and can restore gut microbial dysbiosis under various disease conditions." | 5.72 | Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism. ( Cui, Y; Li, XG; Liu, W; Liu, X; Qiu, B; Wang, X; Xiang, G; Yu, M; Zhang, D; Zhang, Y, 2022) |
| "Melatonin plays a beneficial role in gut motility and immunity." | 5.56 | Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis. ( Duan, L; He, M; Liu, Z; Pei, F; Sun, Q; Wang, B; Wei, H; Zhang, J; Zhang, L; Zhu, S, 2020) |
| "Melatonin has shown beneficial effects on obesity, both in humans and experimental models, via regulating the altered circadian rhythm and thus ameliorating the gut dysbiosis associated with this metabolic condition." | 4.12 | The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome. ( Algieri, F; Diez-Echave, P; Duarte, J; Gálvez, J; García, F; Garrido-Mesa, J; Hidalgo-García, L; Morón, R; Rodríguez-Cabezas, ME; Rodríguez-Nogales, A; Romero, M; Ruiz-Malagón, AJ; Sánchez, M; Toral, M; Vezza, T, 2022) |
| " The aim of the present study was to investigate the impact of a short-term feeding with HFD on oxidative status, enteric microbiota, intestinal motility and the effects of antibiotics and/or melatonin treatments on diet-induced hepato-intestinal dysfunction and inflammation." | 3.91 | The effects of antibiotics and melatonin on hepato-intestinal inflammation and gut microbial dysbiosis induced by a short-term high-fat diet consumption in rats. ( Akdeniz, E; Aksu, B; Arabacı Tamer, S; Bagriacik, F; Cayirli, YB; Çetinel, Ş; Cilingir Kaya, ÖT; Kahraman, MM; Onur, ND; Sahin, D; Yeğen, BÇ; Yildirim, A; Yuksel, M, 2019) |
| "Melatonin is an endogenous hormone and can restore gut microbial dysbiosis under various disease conditions." | 1.72 | Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism. ( Cui, Y; Li, XG; Liu, W; Liu, X; Qiu, B; Wang, X; Xiang, G; Yu, M; Zhang, D; Zhang, Y, 2022) |
| "Microbial dysbiosis has long been postulated to be associated with the pathogenesis of inflammatory bowel disease (IBD)." | 1.56 | Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling. ( Cheon, JH; Kim, S; Kim, SW; Park, YS; Son, M, 2020) |
| "Melatonin is a chronobiotic substance that plays a main role in stabilizing bodily rhythm and has shown beneficial effects in protecting against obesity." | 1.56 | Melatonin Orchestrates Lipid Homeostasis through the Hepatointestinal Circadian Clock and Microbiota during Constant Light Exposure. ( Guo, Y; Hong, F; Jia, L; Li, L; Pan, S; Qiao, X; Wang, J; Xu, P; Xue, T; Zhai, Y, 2020) |
| "Our study demonstrated that sleep deprivation resulted in homeostasis disorder of colon." | 1.56 | Melatonin attenuates microbiota dysbiosis of jejunum in short-term sleep deprived mice. ( Cao, J; Chen, Y; Dong, Y; Gao, T; Wang, Z, 2020) |
| "Melatonin plays a beneficial role in gut motility and immunity." | 1.56 | Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis. ( Duan, L; He, M; Liu, Z; Pei, F; Sun, Q; Wang, B; Wei, H; Zhang, J; Zhang, L; Zhu, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 11 (73.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, B | 1 |
| Chen, T | 1 |
| Cao, M | 1 |
| Yuan, C | 1 |
| Reiter, RJ | 1 |
| Zhao, Z | 1 |
| Zhao, Y | 1 |
| Chen, L | 1 |
| Fan, W | 1 |
| Wang, X | 4 |
| Zhou, X | 1 |
| Li, C | 1 |
| Diez-Echave, P | 1 |
| Vezza, T | 1 |
| Algieri, F | 1 |
| Ruiz-Malagón, AJ | 1 |
| Hidalgo-García, L | 1 |
| García, F | 1 |
| Morón, R | 1 |
| Sánchez, M | 1 |
| Toral, M | 1 |
| Romero, M | 1 |
| Duarte, J | 1 |
| Garrido-Mesa, J | 1 |
| Rodríguez-Cabezas, ME | 1 |
| Rodríguez-Nogales, A | 1 |
| Gálvez, J | 1 |
| Liu, X | 3 |
| Cui, Y | 3 |
| Zhang, Y | 3 |
| Xiang, G | 3 |
| Yu, M | 3 |
| Qiu, B | 3 |
| Li, XG | 3 |
| Liu, W | 3 |
| Zhang, D | 3 |
| Lian, Z | 1 |
| Xu, Y | 1 |
| Wang, C | 1 |
| Chen, Y | 3 |
| Yuan, L | 1 |
| Liu, Z | 2 |
| Liu, Y | 1 |
| He, P | 1 |
| Cai, Z | 1 |
| Zhao, J | 1 |
| Li, X | 1 |
| Wang, F | 1 |
| Gao, Z | 1 |
| Huang, W | 1 |
| Zhang, X | 1 |
| Liu, F | 1 |
| Yi, H | 1 |
| Guan, J | 1 |
| Wu, X | 1 |
| Xu, H | 1 |
| Yin, S | 1 |
| Anderson, G | 2 |
| Maes, M | 1 |
| Kim, SW | 1 |
| Kim, S | 1 |
| Son, M | 1 |
| Cheon, JH | 1 |
| Park, YS | 1 |
| Hong, F | 1 |
| Pan, S | 1 |
| Xu, P | 1 |
| Xue, T | 1 |
| Wang, J | 1 |
| Guo, Y | 1 |
| Jia, L | 1 |
| Qiao, X | 1 |
| Li, L | 1 |
| Zhai, Y | 1 |
| Gao, T | 2 |
| Wang, Z | 2 |
| Cao, J | 2 |
| Dong, Y | 2 |
| Wang, B | 1 |
| Zhu, S | 1 |
| Wei, H | 1 |
| Zhang, L | 1 |
| He, M | 1 |
| Pei, F | 1 |
| Zhang, J | 1 |
| Sun, Q | 1 |
| Duan, L | 1 |
| Lin, R | 1 |
| Jing, Y | 1 |
| Yang, D | 1 |
| Bai, F | 1 |
| Zhang, C | 1 |
| Qin, C | 1 |
| Li, D | 1 |
| Wang, L | 1 |
| Yang, M | 1 |
| Chen, Z | 1 |
| Li, J | 1 |
| Yildirim, A | 1 |
| Arabacı Tamer, S | 1 |
| Sahin, D | 1 |
| Bagriacik, F | 1 |
| Kahraman, MM | 1 |
| Onur, ND | 1 |
| Cayirli, YB | 1 |
| Cilingir Kaya, ÖT | 1 |
| Aksu, B | 1 |
| Akdeniz, E | 1 |
| Yuksel, M | 1 |
| Çetinel, Ş | 1 |
| Yeğen, BÇ | 1 |
| Gevi, F | 1 |
| Zolla, L | 1 |
| Gabriele, S | 1 |
| Persico, AM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gut Mobilization With Oral Administration of Polyethylene Glycol (PEG) at the Dose of 6.9 g/d Once a Day for 6 Months in Chronically Constipated Autistic Children.[NCT05025553] | 21 participants (Actual) | Interventional | 2018-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for melatonin and Disbacteriosis
| Article | Year |
|---|---|
Integrating Pathophysiology in Migraine: Role of the Gut Microbiome and Melatonin.
Topics: Astrocytes; Dysbiosis; Gastrointestinal Microbiome; Humans; Melatonin; Migraine Disorders; Mitochond | 2019 |
Gut Dysbiosis Dysregulates Central and Systemic Homeostasis via Suboptimal Mitochondrial Function: Assessment, Treatment and Classification Implications.
Topics: Butyric Acid; Cell Line; Dysbiosis; Gastrointestinal Microbiome; Homeostasis; Humans; Immune System; | 2020 |
13 other studies available for melatonin and Disbacteriosis
| Article | Year |
|---|---|
Gut Microbiota Dysbiosis Induced by Decreasing Endogenous Melatonin Mediates the Pathogenesis of Alzheimer's Disease and Obesity.
Topics: Alzheimer Disease; Animals; Dysbiosis; Gastrointestinal Microbiome; Inflammation; Melatonin; Mice; O | 2022 |
The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome.
Topics: Acetamides; Animals; Diet, High-Fat; Dysbiosis; Gastrointestinal Microbiome; Humans; Male; Melatonin | 2022 |
Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism.
Topics: Akkermansia; Animals; Autism Spectrum Disorder; Autistic Disorder; Dietary Supplements; Disease Mode | 2022 |
Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism.
Topics: Akkermansia; Animals; Autism Spectrum Disorder; Autistic Disorder; Dietary Supplements; Disease Mode | 2022 |
Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism.
Topics: Akkermansia; Animals; Autism Spectrum Disorder; Autistic Disorder; Dietary Supplements; Disease Mode | 2022 |
Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism.
Topics: Akkermansia; Animals; Autism Spectrum Disorder; Autistic Disorder; Dietary Supplements; Disease Mode | 2022 |
Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism.
Topics: Akkermansia; Animals; Autism Spectrum Disorder; Autistic Disorder; Dietary Supplements; Disease Mode | 2022 |
Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism.
Topics: Akkermansia; Animals; Autism Spectrum Disorder; Autistic Disorder; Dietary Supplements; Disease Mode | 2022 |
Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism.
Topics: Akkermansia; Animals; Autism Spectrum Disorder; Autistic Disorder; Dietary Supplements; Disease Mode | 2022 |
Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism.
Topics: Akkermansia; Animals; Autism Spectrum Disorder; Autistic Disorder; Dietary Supplements; Disease Mode | 2022 |
Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism.
Topics: Akkermansia; Animals; Autism Spectrum Disorder; Autistic Disorder; Dietary Supplements; Disease Mode | 2022 |
Gut microbiota-derived melatonin from Puerariae Lobatae Radix-resistant starch supplementation attenuates ischemic stroke injury via a positive microbial co-occurrence pattern.
Topics: Animals; Central Nervous System Depressants; Dysbiosis; Gastrointestinal Microbiome; Ischemic Stroke | 2023 |
Melatonin attenuates chronic intermittent hypoxia-induced intestinal barrier dysfunction in mice.
Topics: Animals; Caco-2 Cells; Cytokines; Dysbiosis; Gastrointestinal Diseases; Humans; Hypoxia; Melatonin; | 2023 |
Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling.
Topics: Animals; Bacteroidetes; Cell Differentiation; Colitis, Ulcerative; Dextran Sulfate; Disease Models, | 2020 |
Melatonin Orchestrates Lipid Homeostasis through the Hepatointestinal Circadian Clock and Microbiota during Constant Light Exposure.
Topics: Animals; Cell Line; Circadian Clocks; Circadian Rhythm; Dysbiosis; Gastrointestinal Microbiome; Hepa | 2020 |
Melatonin attenuates microbiota dysbiosis of jejunum in short-term sleep deprived mice.
Topics: Aeromonadaceae; Animals; Antioxidants; Bacteroidaceae; Dysbiosis; Firmicutes; Gastrointestinal Micro | 2020 |
Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis.
Topics: Animals; Diarrhea; Dysbiosis; Humans; Irritable Bowel Syndrome; Melatonin; Rats | 2020 |
Role of melatonin in murine "restraint stress"-induced dysfunction of colonic microbiota.
Topics: Animals; Antioxidants; Bacteria; Colon; Dysbiosis; Gastrointestinal Microbiome; Inflammation; Intest | 2021 |
Melatonin Treatment Alleviates Spinal Cord Injury-Induced Gut Dysbiosis in Mice.
Topics: Animals; Dysbiosis; Female; Gastrointestinal Microbiome; Melatonin; Mice; Mice, Inbred C57BL; Neurop | 2019 |
The effects of antibiotics and melatonin on hepato-intestinal inflammation and gut microbial dysbiosis induced by a short-term high-fat diet consumption in rats.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Colon; Diet, High-Fat; Disease Models, Animal; Dysbios | 2019 |
Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.
Topics: Autism Spectrum Disorder; Biomarkers; Case-Control Studies; Child; Child, Preschool; Chromatography, | 2016 |